Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia.

DeAngelo, Daniel J; Jonas, Brian A; Liesveld, Jane L; Bixby, Dale L; Advani, Anjali S; Marlton, Paula; Magnani, John L; Thackray, Helen M; Feldman, Eric J; O'Dwyer, Michael E; Becker, Pamela S

DeAngelo, Daniel J; Jonas, Brian A; Liesveld, Jane L; Bixby, Dale L; Advani, Anjali S; Marlton, Paula; Magnani, John L; Thackray, Helen M; Feldman, Eric J; O'Dwyer, Michael E; Becker, Pamela S.

Affiliation

DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Jonas BA; UC Davis Comprehensive Cancer Center, Sacramento, CA.
Liesveld JL; Department of Medicine, Hematology/Oncology, University of Rochester School of Medicine and Dentistry, Rochester, NY.
Bixby DL; Department of Hematology/Oncology, University of Michigan, Ann Arbor, MI.
Advani AS; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
Marlton P; Princess Alexandra Hospital, University of Queensland School of Medicine, Brisbane, QLD, Australia.
Magnani JL; GlycoMimetics, Rockville, MD.
Thackray HM; GlycoMimetics, Rockville, MD.
Feldman EJ; GlycoMimetics, Rockville, MD.
O'Dwyer ME; Department of Haematology, National University of Ireland Galway, Galway, Ireland; and.
Becker PS; University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA.

Blood ; 139(8): 1135-1146, 2022 02 24.

Article in En | MEDLINE | ID: mdl-34543383

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glycolipids / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2022 Document type: Article Affiliation country: Marruecos Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google